Here go the Marxist Inverters (part 2)
p.s. This is a way to push the new commercially available versions AND blame Trump!
IF YOU AREN’T READY TO PUKE 🤮 AFTER READING THIS, YOU SHOULDN’T BE READING THIS. 🤮
(WWLP) – The second COVID-19 booster is not yet available to everyone, only those 50 years or older or individuals with certain medical conditions.
1st COVID-19 Booster
The first booster dose of the Pfizer (now known as Comirnaty), and Moderna (now renamed Spikevax) COVID-19 vaccine is recommended to everyone 5 years and older after they have had their primary vaccine series.
Pfizer or Moderna at least 3 months since fully vaccinated.
Johnson & Johnson at least 2 months since being vaccinated.
2nd COVID-19 Booster
The second booster dose of the COVID-19 vaccine was authorized by the U.S. Food and Drug Administration (FDA) on March 29th and can be administered at least 4 months after receiving the first booster of any COVID-19 vaccine for the following:
Pfizer or Moderna for those 50 years or older.
Pfizer for those 12 years or older with certain immunocompromised conditions, or living with someone who is has a weakened immune system.
Moderna for those 18 years or older with certain immunocompromised conditions.
COVID-19 vaccines for children 6 months to 5 years old were approved on June 20, 2022.
A protein-based vaccine, Novavax was authorized by the FDA on July 13, 2022 to adults 18 years or older and on August 22nd to 12 years old and up as a two-dose primary series, three weeks apart for those who have not yet been vaccinated at all. The CDC recommended Novavax as a fourth COVID-19 vaccine option in the U.S.
“Current evidence suggests some waning of protection over time against serious outcomes from COVID-19 in older and immunocompromised individuals. Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine could help increase protection levels for these higher-risk individuals,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “Additionally, the data show that an initial booster dose is critical in helping to protect all adults from the potentially severe outcomes of COVID-19. So, those who have not received their initial booster dose are strongly encouraged to do so.”
IN CLOSING: 🤮
ALSO: I love you guys…not in the creepy way…NEVER comply.